Developer docs
API playgroundTry for free, no card

Search company profiles

Wondermed

Full company profile

uuid0002qlh

Namestring
Wondermed
Legal namestring
WondermedAI
Websiteurl
wondermed.com
Company typeenum
Private
Founded yearint
2020
Descriptiontext

Wondermed (legal entity WondermedAI) is a US-based precision mental healthcare company founded in 2020 and headquartered in Venice, California, that operates a telemedicine platform pairing patients nationwide with licensed physicians for psychedelic- and somatic-based treatment protocols. The company employs 11-50 people and serves patient segments including individuals with anxiety, depression, and chronic pain, with an explicit positioning around non-opioid alternatives for chronic pain and AI-assisted opioid tapering. It markets to patients via a waitlist, direct consumer acquisition and to clinicians through a sales-led provider-recruitment motion intended to convert practices into mental-health centers of excellence.

The company's core offering is Wondermed*AI*, an AI platform that integrates clinician prescribing data, patient experience data, and between-visit monitoring into a unified personalization layer using instruments such as PHQ-9 and GAD-7. On top of this core, the company markets three sub-products: Wonder AI Pharmacology (an AI system supporting medication selection, dosing, and duration for psychiatric pharmacotherapy), Wonder Relief (a 12-week virtual chronic-pain protocol combining low-dose ketamine with supplements, CBT, mindfulness, and coaching, with AI-assisted tapering and real-time safety alerts under the FDA 505(b)(2) pathway, NDA targeted 2030), and WonderFlow V2 (an anxiety/depression protocol built on flow-state neuroscience using proprietary Wonder Ketamine Lozenges and a daily supplement under the FDA 505(b)(2) pathway, NDA targeted 2031). Supporting proprietary assets include an AI abuse-surveillance system, adaptive dosing engines, and 1,500+ patient IRB-backed clinical data used to inform protocol refinement.

Wondermed generates revenue primarily through recurring telemedicine service subscriptions, distributed through its direct-to-consumer app and web platform as well as through a recruited provider network that delivers clinical care. GTM combines waitlist-based top-of-funnel demand capture with a provider-facing sales motion and clinical trial recruitment. Capital structure disclosure is limited: a single $4.6M funding round closed in June 2022 is the only event on record, no parent company, subsidiaries, or M&A activity is reported, and no regulatory actions against the company are noted. Academic institution partnerships support the FDA 505(b)(2) clinical development but the partner is unnamed in available sources.

Short descriptiontext

Wondermed is a US-based telemedicine company offering AI-powered precision mental healthcare that pairs patients with physicians for psychedelic- and somatic-based protocols targeting anxiety, depression, and chronic pain via FDA 505(b)(2) pathway programs.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersVenice, United States
HQ citystring
Venice
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
precision mental healthcare, ketamine telemedicine, AI psychiatry platform, chronic pain treatment, psychedelic protocols
Industry3 codes
PRIMARYHLALAEAA
General Mental Health Therapy Platforms (Talk Therapy)
Healthcare & Life Sciences/Telehealth Platforms/Behavioral & Mental Health Teletherapy Platforms
SECONDARYHLACANAD
Software as a Medical Device (SaMD) – Clinical Decision & Diagnostic Software
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHDAAAGAI
Healthcare & Wellness Personalization
NAICS code3 codes
  • Offices of Physicians, Mental Health Specialists621112
  • Offices of Mental Health Practitioners (except Physicians)621330
  • Offices of Physicians (except Mental Health Specialists)621111
SIC code3 codes
  • Services-Misc Health & Allied Services, Nec8090
  • Services-Offices & Clinics Of Doctors Of Medicine8011
  • Services-Health Services8000
Product category
Digital Mental Healthcare / Telemedicine Psychiatry
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Telemedicine Services
TypeSubscription Recurring
Description

Revenue generated from telemedicine-based mental healthcare services delivered to patients, including AI-guided protocols for anxiety, depression, and chronic pain conditions.

wondermed.ai
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 of 4 records shown
1Wondermed AI
Description

AI platform connecting prescribing, patient experience, and between-visit data to personalize mental healthcare.

wondermed.ai
+3 more records
Core offering1 text field

Wondermed is a precision mental healthcare company that delivers AI-guided psychiatric and chronic pain treatment protocols via telemedicine. Its core offering combines proprietary ketamine-based therapies (Wonder Relief for chronic pain, WonderFlow for anxiety and depression) with the Wondermed AI platform that personalizes medication selection, dosing, and ongoing monitoring for each patient. Licensed clinicians deliver care remotely through the Wondermed app and web platform nationwide.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Validated from 1,500+ patients with IRB-backed clinical data
Product overview1 text field

Wondermed is a precision mental healthcare company offering a platform of AI-powered products. The core system is Wondermed AI, which connects prescribing data, patient experiences, and between-visit information to personalize care. Key products include Wonder AI Pharmacology for medication guidance, Wonder Relief for chronic pain management via ketamine protocol, and WonderFlow V2 for anxiety and depression treatment using flow-state neuroscience. Supporting offerings include proprietary Wonder Ketamine Lozenges and WonderFlow Daily Supplement. All products integrate AI personalization with clinical oversight, targeting FDA 505(b)(2) regulatory pathways.

Product and service6 records
1Wondermed AI
CategoryAI Platform
Description

Core AI platform that connects prescribing data, patient experiences, and between-visit information to personalize mental healthcare delivery to every patient. Includes adaptive dosing, real-time safety alerts, and AI abuse surveillance. Aimed at patients receiving mental healthcare through the Wondermed telemedicine service.

2Wonder AI Pharmacology
CategoryAI Pharmacology
Description

AI-powered system supporting personalized psychiatric pharmacotherapy by guiding medication selection, dosing, and duration using patient response data. Designed for mental health patients seeking precision medication management.

3Wonder Relief
CategoryChronic Pain Treatment
Description

12-week virtual protocol providing a safer non-opioid alternative for chronic pain management. Combines low-dose ketamine, supplements, CBT, mindfulness, and coaching with AI-assisted opioid tapering and real-time safety monitoring. Aimed at patients with chronic pain conditions seeking alternatives to opioid therapy.

4WonderFlow V2
CategoryMental Health Treatment
Description

AI-guided protocol for anxiety and depression built on flow state neuroscience. Incorporates Wonder Ketamine Lozenges, WonderFlow Daily Supplement, and adaptive AI personalization for dosing and intervention pathways. Designed for patients with anxiety and depression seeking psychedelic-assisted treatment.

5Wonder Ketamine Lozenges
CategoryProprietary Medication
Description

Proprietary ketamine formulation (100-400mg) paired with cannabinoids, administered 4-8x monthly as a neuromodulatory primer for flow-state induction. Used within the WonderFlow V2 protocol for anxiety and depression patients.

6WonderFlow Daily Supplement
CategoryWellness Supplement
Description

Daily organic supplement featuring functional mushrooms and botanicals designed to support neuroplasticity, recovery, and treatment continuity as part of the WonderFlow protocol.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Wondermed has established partnerships with leading academic institutions to support its FDA 505(b)(2) pathway clinical development programs for Wonder Relief (chronic pain) and WonderFlow V2 (anxiety and depression). These academic partnerships provide clinical research expertise and institutional oversight for the company's regulatory development programs.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1K Health
TypeEmerging player
Description

AI-powered telehealth platform combining chatbot triage with clinician visits for primary care and mental health. Comparable to Wondermed's AI-first clinical decision-support approach layered on top of telemedicine delivery.

TypeBroad incumbent
Description

Public telepsychiatry and online therapy platform serving consumers, employers, and payers. Comparable to Wondermed for online talk therapy plus psychiatric medication management via subscription.

TypeEmerging player
Description

Clinical-stage psychedelic therapy developer (psilocybin) pursuing FDA approval for treatment-resistant depression. Comparable to Wondermed in pursuing regulated, FDA-pathway psychedelic/ketamine therapies for mental-health indications.

TypeDirect peer
Description

Direct-to-consumer telemedicine platform for anxiety, depression, and ADHD with medication management. Comparable to Wondermed in offering AI-/clinician-supported psychiatric prescribing via a subscription telehealth model serving U.S. patients.

TypeDirect peer
Description

At-home ketamine therapy provider for depression and anxiety with guided protocols and clinician oversight. Most direct functional peer to Wondermed's WonderFlow/Wonder Relief ketamine-based mental-health and chronic-pain protocols.

TypeBroad incumbent
Description

Large-scale D2C telehealth platform spanning mental health, dermatology, and primary care with subscription prescribing. Overlaps with Wondermed on subscription telepsychiatry and AI-supported clinical workflows, though at vastly greater scale and category breadth.

TypeBroad incumbent
Description

Enterprise mental-health benefit platform offering therapy, coaching, and medication management to employees via employers. Comparable to Wondermed's B2B/provider-network GTM orientation and AI-augmented mental-healthcare delivery.

TypeBroad incumbent
Description

Largest direct-to-consumer online therapy subscription service. Comparable to Wondermed as a high-volume subscription tele-mental-health platform, though BetterHelp focuses on talk therapy rather than AI-guided pharmacotherapy.

TypeBroad incumbent
Description

Enterprise mental-health platform combining therapy, coaching, and medication management with a precision-matching engine. Comparable to Wondermed's AI-personalization philosophy and outcomes-driven mental-healthcare positioning.

10Field Trip Health
TypeEmerging player
Description

Psychedelic-assisted therapy provider operating ketamine clinics for depression and related conditions. Comparable to Wondermed's use of ketamine protocols in mental-health treatment, though delivered in clinic rather than virtual.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Wondermed

Digital Mental Healthcare / Telemedicine Psychiatrywondermed.com

Wondermed is a US-based telemedicine company offering AI-powered precision mental healthcare that pairs patients with physicians for psychedelic- and somatic-based protocols targeting anxiety, depression, and chronic pain via FDA 505(b)(2) pathway programs.

What Wondermed does

Wondermed (legal entity WondermedAI) is a US-based precision mental healthcare company founded in 2020 and headquartered in Venice, California, that operates a telemedicine platform pairing patients nationwide with licensed physicians for psychedelic- and somatic-based treatment protocols. The company employs 11-50 people and serves patient segments including individuals with anxiety, depression, and chronic pain, with an explicit positioning around non-opioid alternatives for chronic pain and AI-assisted opioid tapering. It markets to patients via a waitlist, direct consumer acquisition and to clinicians through a sales-led provider-recruitment motion intended to convert practices into mental-health centers of excellence.

The company's core offering is Wondermed*AI*, an AI platform that integrates clinician prescribing data, patient experience data, and between-visit monitoring into a unified personalization layer using instruments such as PHQ-9 and GAD-7. On top of this core, the company markets three sub-products: Wonder AI Pharmacology (an AI system supporting medication selection, dosing, and duration for psychiatric pharmacotherapy), Wonder Relief (a 12-week virtual chronic-pain protocol combining low-dose ketamine with supplements, CBT, mindfulness, and coaching, with AI-assisted tapering and real-time safety alerts under the FDA 505(b)(2) pathway, NDA targeted 2030), and WonderFlow V2 (an anxiety/depression protocol built on flow-state neuroscience using proprietary Wonder Ketamine Lozenges and a daily supplement under the FDA 505(b)(2) pathway, NDA targeted 2031). Supporting proprietary assets include an AI abuse-surveillance system, adaptive dosing engines, and 1,500+ patient IRB-backed clinical data used to inform protocol refinement.

Wondermed generates revenue primarily through recurring telemedicine service subscriptions, distributed through its direct-to-consumer app and web platform as well as through a recruited provider network that delivers clinical care. GTM combines waitlist-based top-of-funnel demand capture with a provider-facing sales motion and clinical trial recruitment. Capital structure disclosure is limited: a single $4.6M funding round closed in June 2022 is the only event on record, no parent company, subsidiaries, or M&A activity is reported, and no regulatory actions against the company are noted. Academic institution partnerships support the FDA 505(b)(2) clinical development but the partner is unnamed in available sources.

Wondermed firmographics

Firmographics
Name
Wondermed
Legal name
WondermedAI
Website
https://wondermed.com
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
1–10 employees
Short description
Wondermed is a US-based telemedicine company offering AI-powered precision mental healthcare that pairs patients with physicians for psychedelic- and somatic-based protocols targeting anxiety, depression, and chronic pain via FDA 505(b)(2) pathway programs.
Ownership category
akta.pro rank

Wondermed industry classification

Industry
Product category
Digital Mental Healthcare / Telemedicine Psychiatry
NAICS
Offices of Physicians, Mental Health Specialists (621112), Offices of Mental Health Practitioners (except Physicians) (621330), Offices of Physicians (except Mental Health Specialists) (621111)
SIC
Services-Misc Health & Allied Services, Nec (8090), Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)
akta.pro industry
PRIMARYHLALAEAA
General Mental Health Therapy Platforms (Talk Therapy)
Healthcare & Life Sciences/Telehealth Platforms/Behavioral & Mental Health Teletherapy Platforms
SECONDARYHLACANAD
Software as a Medical Device (SaMD) – Clinical Decision & Diagnostic Software
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHDAAAGAI
Healthcare & Wellness Personalization

Keywords

  • Precision mental healthcare
  • Ketamine telemedicine
  • AI psychiatry platform
  • Chronic pain treatment
  • Psychedelic protocols

Where Wondermed is headquartered

Location

Headquarters

HQ city
Venice
HQ country
United States
HQ region
North America

Markets served

Wondermed business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Telemedicine Services: Revenue generated from telemedicine-based mental healthcare services delivered to patients, including AI-guided protocols for anxiety, depression, and chronic pain conditions.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Wondermed product offering

Product offering

Core offering

Wondermed is a precision mental healthcare company that delivers AI-guided psychiatric and chronic pain treatment protocols via telemedicine. Its core offering combines proprietary ketamine-based therapies (Wonder Relief for chronic pain, WonderFlow for anxiety and depression) with the Wondermed AI platform that personalizes medication selection, dosing, and ongoing monitoring for each patient. Licensed clinicians deliver care remotely through the Wondermed app and web platform nationwide.

Product overview

Wondermed is a precision mental healthcare company offering a platform of AI-powered products. The core system is Wondermed AI, which connects prescribing data, patient experiences, and between-visit information to personalize care. Key products include Wonder AI Pharmacology for medication guidance, Wonder Relief for chronic pain management via ketamine protocol, and WonderFlow V2 for anxiety and depression treatment using flow-state neuroscience. Supporting offerings include proprietary Wonder Ketamine Lozenges and WonderFlow Daily Supplement. All products integrate AI personalization with clinical oversight, targeting FDA 505(b)(2) regulatory pathways.

Differentiator

Problem solved

Functional benefit

Brands

  • Wondermed AI: AI platform connecting prescribing, patient experience, and between-visit data to personalize mental healthcare.
  • Wonder AI Pharmacology
  • Wonder Relief
  • WonderFlow / WonderFlow V2

Products and services

  • Wondermed AI Core AI platform that connects prescribing data, patient experiences, and between-visit information to personalize mental healthcare delivery to every patient. Includes adaptive dosing, real-time safety alerts, and AI abuse surveillance. Aimed at patients receiving mental healthcare through the Wondermed telemedicine service.
  • Wonder AI Pharmacology AI-powered system supporting personalized psychiatric pharmacotherapy by guiding medication selection, dosing, and duration using patient response data. Designed for mental health patients seeking precision medication management.
  • Wonder Relief 12-week virtual protocol providing a safer non-opioid alternative for chronic pain management. Combines low-dose ketamine, supplements, CBT, mindfulness, and coaching with AI-assisted opioid tapering and real-time safety monitoring. Aimed at patients with chronic pain conditions seeking alternatives to opioid therapy.
  • WonderFlow V2 AI-guided protocol for anxiety and depression built on flow state neuroscience. Incorporates Wonder Ketamine Lozenges, WonderFlow Daily Supplement, and adaptive AI personalization for dosing and intervention pathways. Designed for patients with anxiety and depression seeking psychedelic-assisted treatment.
  • Wonder Ketamine Lozenges Proprietary ketamine formulation (100-400mg) paired with cannabinoids, administered 4-8x monthly as a neuromodulatory primer for flow-state induction. Used within the WonderFlow V2 protocol for anxiety and depression patients.
  • WonderFlow Daily Supplement Daily organic supplement featuring functional mushrooms and botanicals designed to support neuroplasticity, recovery, and treatment continuity as part of the WonderFlow protocol.

Quantifiable outcome

  • Validated from 1,500+ patients with IRB-backed clinical data

Companies that use Wondermed

Customer profile

Segments3 records

Ideal customer profiles3 records

Wondermed technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature6 records

Wondermed partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Leading Academic Partner (Unnamed)coreStrategic or Co-development PartnerWondermed has established partnerships with leading academic institutions to support its FDA 505(b)(2) pathway clinical development programs for Wonder Relief (chronic pain) and WonderFlow V2 (anxiety and depression). These academic partnerships provide clinical research expertise and institutional oversight for the company's regulatory development programs.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Wondermed competitors and assessment

Company assessment

Emerging players

  • K Health: AI-powered telehealth platform combining chatbot triage with clinician visits for primary care and mental health. Comparable to Wondermed's AI-first clinical decision-support approach layered on top of telemedicine delivery.
  • Compass Pathways: Clinical-stage psychedelic therapy developer (psilocybin) pursuing FDA approval for treatment-resistant depression. Comparable to Wondermed in pursuing regulated, FDA-pathway psychedelic/ketamine therapies for mental-health indications.
  • Field Trip Health: Psychedelic-assisted therapy provider operating ketamine clinics for depression and related conditions. Comparable to Wondermed's use of ketamine protocols in mental-health treatment, though delivered in clinic rather than virtual.

Broad incumbents

  • Talkspace: Public telepsychiatry and online therapy platform serving consumers, employers, and payers. Comparable to Wondermed for online talk therapy plus psychiatric medication management via subscription.
  • Hims & Hers Health: Large-scale D2C telehealth platform spanning mental health, dermatology, and primary care with subscription prescribing. Overlaps with Wondermed on subscription telepsychiatry and AI-supported clinical workflows, though at vastly greater scale and category breadth.
  • Lyra Health: Enterprise mental-health benefit platform offering therapy, coaching, and medication management to employees via employers. Comparable to Wondermed's B2B/provider-network GTM orientation and AI-augmented mental-healthcare delivery.
  • BetterHelp: Largest direct-to-consumer online therapy subscription service. Comparable to Wondermed as a high-volume subscription tele-mental-health platform, though BetterHelp focuses on talk therapy rather than AI-guided pharmacotherapy.
  • Spring Health: Enterprise mental-health platform combining therapy, coaching, and medication management with a precision-matching engine. Comparable to Wondermed's AI-personalization philosophy and outcomes-driven mental-healthcare positioning.

Direct peers

  • Cerebral: Direct-to-consumer telemedicine platform for anxiety, depression, and ADHD with medication management. Comparable to Wondermed in offering AI-/clinician-supported psychiatric prescribing via a subscription telehealth model serving U.S. patients.
  • Mindbloom: At-home ketamine therapy provider for depression and anxiety with guided protocols and clinician oversight. Most direct functional peer to Wondermed's WonderFlow/Wonder Relief ketamine-based mental-health and chronic-pain protocols.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

Wondermed social profiles

Digital presence

Wondermed financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Wondermed leadership team

Management profile

Number of profiles

Profiles1 record

Wondermed funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Wondermed M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Wondermed

What does Wondermed do?

Wondermed is a precision mental healthcare company that delivers AI-guided psychiatric and chronic pain treatment protocols via telemedicine. Its core offering combines proprietary ketamine-based therapies (Wonder Relief for chronic pain, WonderFlow for anxiety and depression) with the Wondermed AI platform that personalizes medication selection, dosing, and ongoing monitoring for each patient. Licensed clinicians deliver care remotely through the Wondermed app and web platform nationwide.

Is Wondermed a public or private company?

Wondermed is a private company. It is classified as unknown and is currently operating.

When was Wondermed founded?

Wondermed was founded in 2020. It employs 1 to 10 people.

Where is Wondermed based?

Wondermed is headquartered in Venice, United States, in the North America region.

How does Wondermed make money?

One revenue line is on record: telemedicine Services.

Who are Wondermed's main competitors?

Emerging players on record are K Health, Compass Pathways and Field Trip Health. Broad incumbents are Talkspace, Hims & Hers Health, Lyra Health, BetterHelp and Spring Health. Direct peers are Cerebral and Mindbloom.

Does Wondermed have an API?

No public API is recorded for Wondermed.

What industry is Wondermed in?

Wondermed's product category is Digital Mental Healthcare / Telemedicine Psychiatry. Its primary akta.pro industry code is HLALAEAA, General Mental Health Therapy Platforms (Talk Therapy), with a secondary code of HLACANAD, Software as a Medical Device (SaMD) – Clinical Decision & Diagnostic Software. Its NAICS code is 621112 and its SIC code is 8090.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals